Lantern Pharma Inc LTRN

US Biotechnology

$1.22 ▲ +0.83% (+$0.01)

🎈 Low Float 🎢 High Beta

Open $1.19

Prev Close $1.21

Day Range $1.16 – $1.28

52W Range $1.11 – $4.70

Market Cap $15.60M

Beta 2.41

EPS (TTM) $-1.61

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2020-06-11
Shares Out.	12,760,000
Website	lanternpharma.com/ ↗
Phone	19722771136
Employees	16
Revenue	$0
Gross Profit	$0
Net Income	-$7.1M
Free Cash Flow	-$14.1M
Total Assets	$8.6M
Total Liabilities	$11.8M
Equity	-$3.2M

About Lantern Pharma Inc

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Lantern Pharma Inc is a publicly traded company under the ticker symbol LTRN on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.